Navigation Links
The New York Stem Cell Foundation announces new initiative for Parkinson's disease
Date:6/22/2011

NEW YORK CITY (June 22, 2011)The New York Stem Cell Foundation (NYSCF) has received a half-million dollar gift from the Golub family to launch the NYCF-Golub Stem Cell Initiative for Parkinson's Disease. The initiative permits researchers in the NYSCF Laboratory to use a novel approach to understand Parkinson's disease that includes the creation of stem cell lines from a genetically diverse population of Parkinson's patients.

The announcement was made at the NYSCF Laboratory by the organization's CEO Susan L. Solomon, NYSCF Board Chairman Dr. Roy Geronemus, and Lawrence E. Golub, President of Golub Capital, and his wife Karen Finerman, President and CEO of Metropolitan Capital Advisors.

According to Ms. Solomon, the NYSCF Golub Initiative provides a remarkable opportunity to advance the search for better therapies for Parkinson's disease, and supports a dedicated team of Parkinson's researchers in the NYSCF Laboratory. The research will include creating stem cell lines from a genetically diverse population of Parkinson's patients, which will be part of a large bank of lines that will greatly accelerate the creating of new drugs and therapies on actual cells that are dying of the disease. It will permit NYSCF researchers and their collaborators to screen for drugs that slow or stop the progression of Parkinson's disease.

"We are so grateful to Lawrence Golub and Karen Finerman for their generous support of a new approach that holds so much promise for this debilitating disease that creates so much suffering for patients and their families," says Ms. Solomon. "This is an incredible opportunity to advance the search for better treatments for Parkinson's disease. The current therapies are just not acceptable."

"Our goal is to accelerate treatments and translational work that pharmaceutical companies are not prepared to do," said Mr. Golub, who explains the lines will be made available to qualified private and public sector scientists for research purposes. "NYSCF has the right people and the right lab to get the job done. Our goal is to create a drug-testing factory that turns raw science into drugs for the public sector."


'/>"/>

Contact: Nadine Woloshin
nwoloshin@rubenstein.com
212-843-8041
New York Stem Cell Foundation
Source:Eurekalert

Related medicine news :

1. Damon Runyon Cancer Research Foundation awards $3.45 million to 9 top young clinical investigators
2. SIR Foundation sets research priorities for minimally invasive treatments for MS patients
3. Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
4. Outstanding high school students receive AGA Research Foundation Fellowship Awards
5. The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists
6. MetLife Foundations grant bolsters media coverage for aging issues
7. John Theurer Cancer Center and the Promise Foundation partner to offer free skin cancer screenings
8. Cole Foundation injects $700,000 into childhood cancer research
9. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
10. Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones
11. AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
Breaking Medicine Technology: